Search results for "FDA update"

Results 21 - 30 of about 98 for "FDA update".

Warning about serious genital infections in patients taking SGLT2 inhibitors | ACP Diabetes Monthly

The FDA has identified 12 cases of necrotizing fasciitis of the perineum or Fournier's gangrene. All 12 patients were hospitalized and required surgery, and one died.

Glucose monitoring system approved specifically for critical care units | ACP Diabetes Monthly

The FDA recently approved a new indication for the Nova StatStrip Glucose Hospital Meter System, extending its use to critically ill patients who have been hospitalized.

Aflibercept approved for diabetic retinopathy in diabetic macular edema | ACP Diabetes Monthly

Aflibercept (Eylea) has received expanded approval to treat diabetic retinopathy (DR) in patients with diabetic macular edema (DME), the FDA recently announced.

Olmesartan passes safety review | ACP Diabetes Monthly

The benefits of the angiotensin-receptor blocker olmesartan continue to outweigh the risks for diabetic patients, according to the FDA.

Device approved to treat diabetic foot ulcers | ACP Diabetes Monthly

The shock-wave system is intended to be used with standard diabetic ulcer care in patients ages 22 years and older with ulcers lasting more than 30 days.

CGM system approved for use without finger sticks | ACP Diabetes Monthly

A continuous glucose monitoring (CGM) system was approved and some infusion sets were recalled, the FDA recently announced.

New daily injection approved for adults with type 2 diabetes | ACP Diabetes Monthly

Lixisenatide (Adlyxin), a once-daily injection, was approved by the FDA on July 28 to improve glycemic control in adults with type 2 diabetes.

Metformin solution recalled due to contamination | ACP Diabetes Monthly

Two lots of metformin hydrochloride oral solution (Riomet), 500 mg/5 mL, were recalled due to fungal contamination, the FDA said.

Safety alert and advice on CT scanning in patients with insulin pumps | ACP Diabetes Monthly

The presence of an insulin pump should not preclude an appropriate and medically indicated CT scan, the FDA said.

Continuous glucose monitoring system approved to direct therapy, but daily fingersticks still needed | ACP Diabetes Monthly

The G5 Mobile Continuous Glucose Monitoring System is now approved for patients and clinicians to use results directly from the device to make diabetes treatment decisions.

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next